--2025/Q2-- / 3.730M--
--2025/Q1-- / 5.000M--
Feb 27, 20252024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Intel
INTC
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 4.320
- -0.180-4.00%
Close Mar 3 16:00 ET
204.01MMarket Cap-3.44P/E (TTM)
4.620High4.290Low211.45KVolume4.500Open4.500Pre Close932.18KTurnover0.82%Turnover RatioLossP/E (Static)47.22MShares27.72052wk High1.20P/B111.66MFloat Cap4.06052wk Low--Dividend TTM25.85MShs Float35.000Historical High--Div YieldTTM7.33%Amplitude4.060Historical Low4.408Avg Price1Lot Size
Silence Therapeutics Key Stats
Silence Therapeutics Q4 2024 Earnings Date
Currency：USDFeb 27, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 4.69M | 24.33M | +19.64M |
| Beat Est. | +75.34% | +519.60% | +419.20% |
| EPS | -0.16 | 0.31 | +0.47 |
| Beat Est. | +66.60% | +158.95% | +291.69% |
Analyst Rating
Mar 3, 2025
Silence Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Silence Therapeutics Earnings Reports
Read more